Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Knownews2024-11-22T21:06:45+00:00November 22nd, 2024|The New York Times|
F.D.A.: Some Clonazepam Recalled Over Incorrect Doses on Labelsnews2024-11-22T17:26:32+00:00November 22nd, 2024|The New York Times|
The New York Times Presents: ‘Weight of the World’ on Ozempic’s Risenews2024-11-22T13:48:59+00:00November 22nd, 2024|The New York Times|
Trump’s New Pick for Attorney General, and a Surprise Turn in U.S. Drug Deathsnews2024-11-22T12:14:57+00:00November 22nd, 2024|The New York Times|
Orders for Morning-After Pills and Abortion Pills Rise After Trump’s Electionnews2024-11-19T10:03:41+00:00November 19th, 2024|The New York Times|
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claimsnews2024-11-16T03:21:15+00:00November 16th, 2024|The New York Times|
Can America’s Health Survive Robert F. Kennedy Jr.?news2024-11-16T02:51:41+00:00November 16th, 2024|The New York Times|
Court Hears New York Times Case Against European Commission Over Vaccine Dealnews2024-11-15T18:04:53+00:00November 15th, 2024|The New York Times|
Don’t Blame Biden for Trump’s Victorynews2024-11-15T15:38:02+00:00November 15th, 2024|The New York Times|
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharmanews2024-11-15T15:20:47+00:00November 15th, 2024|The New York Times|
